White Paper

IND Ready Is Not Phase 2 Ready

Download

Download White Paper

The decisions that determine Phase 2 timing are made, or missed, in the first two quarters after the IND opens.

Share

Related Resources

All Resources

Two scientific researchers working in a laboratory setting with a microscope and a laptop

post

Writing a Complex IND: The Top 3 Challenges and How to Avoid Them

Read More

Professionals reviewing documents and data reports

post

Performing CMC Due Diligence for Molecule Licensing and Acquisitions

Read More

Professional in a laboratory setting wearing a lab coat and holding a tablet

post

Why Protocol Amendments Matter: A Clinical Regulatory Medical Writing Perspective

Read More

A gloved hand holds a test tube with pink liquid next to a DNA double helix model

post

Understanding FDA’s Real-Time Oncology Review (RTOR Medical Abbreviation) Program

Read More

Let's move from science to success.